American Red Cross Apheresis Platelets
Apheresis Platelets were distributed without testing for pH or platelet yield.
Recall ended Sep 21, 2026. Still check yours.
Moderate risk
Taking it may cause temporary or medically reversible health problems. Serious harm is unlikely.
FDA Class II recall · How risk is rated
What happened
The American National Red Cross recalled Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced, which were distributed without testing for pH or platelet yield. The recall began on May 19, 2026, and was added to the FDA's Enforcement Report on September 21, 2026.
Summary by Recall Canary from the FDA notice.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these product details with yours, then check the recall notice for any restrictions.
Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced
Details
- Company began the recall
- Event ID
- 99624
- Company
- The American National Red Cross
- Hazard
- Failed specifications
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
